Lung Cancer Trial, Recruiting NCT06532149 Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT06532149
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with advanced or metastatic non-small cell lung cancer (a type of lung cancer that has spread)
  • People who are considered suitable for active treatment by their doctor
  • People aged 18 to 75 years old
  • People who have been sexually active in the 30 days before starting treatment
  • People whose general health and ability to carry out daily activities meets a specific standard (a fitness score of 0 or 1 on a scale used by doctors — confirm with trial site)
  • People who are able and willing to sign a written consent form

Who may not be able to join:

  • People who have a history of hormone-related (endocrine) conditions, except those with well-controlled underactive thyroid (hypothyroidism) who have been on stable thyroid replacement medication for at least 2 years
  • People who have a cancer-related or other medical condition that could affect the study's questionnaires or blood test results
  • People whose cancer or its complications may prevent or seriously affect sexual activity (for example, cancer that has spread to the spine or caused spinal instability, fractures, or uncontrolled nerve-related symptoms)
  • People with a history of chronic liver disease or who are on hormone replacement therapy (for example, hormone treatment for prostate cancer)
  • People who have not fully recovered from damage to the reproductive system caused by previous chemotherapy (for example, treatment with cisplatin)
  • People who regularly take medications known to affect male sexual function, such as opioid pain medicines, anti-anxiety medications, antidepressants, mood stabilisers, certain blood pressure medicines (such as beta blockers), or high-dose water tablets (diuretics)
  • People with a psychiatric condition or substance use disorder that would make it difficult to participate fully in the study
  • People with a significant psychological condition or high levels of emotional distress that could affect sexual function or their ability to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0630156318

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
5 August 2024
Est. completion
5 September 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Incidence of treatment-related sexual dysfuction in male patients with ANSCLC

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov